All stock lists
Bolt Biotherapeutics, Inc. (NASDAQ:BOLT)
US · Delayed Price · Currency is USD
Healthcare · Biotechnology
6.66+0.39 (+6.22%)
Insider Score
––Not scored
BOLT Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
BOLT Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 5.00 K | 26.00 K | 2.50 M | 2.17 M | 1.80 M | 1.22 M |
| Revenue Growth (YoY) | -99.72 % | -97.87 % | — | 90.10 % | 41.49 % | -76.83 % |
| Cost of Revenue | 0.00 | 203.00 K | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 5.00 K | -177.00 K | 2.50 M | 2.17 M | 1.80 M | 1.22 M |
| SG&A Expense | 2.42 M | 2.80 M | 3.12 M | 3.34 M | 3.52 M | 3.83 M |
| R&D Expense | 5.15 M | 4.63 M | 4.99 M | 6.54 M | 7.50 M | 9.51 M |
| Operating Expenses | 8.38 M | 7.42 M | 8.11 M | 9.87 M | 11.01 M | 13.34 M |
| Operating Income | -8.37 M | -7.60 M | -5.61 M | -7.70 M | -9.21 M | -12.12 M |
| Pretax Income | -7.72 M | -7.24 M | -6.63 M | -7.14 M | -8.56 M | -11.04 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -7.72 M | -7.24 M | -6.63 M | -7.14 M | -8.56 M | -11.04 M |
| EPS (Basic) | -4.57 | -3.87 | -3.84 | -3.72 | -4.46 | -0.29 |
| EPS (Diluted) | -4.57 | -3.87 | -3.84 | -3.72 | -4.46 | -0.29 |
| Shares Outstanding | 1.69 M | 1.87 M | 1.87 M | 1.92 M | 1.92 M | 1.92 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.